Form 4 for BLLN BillionToOne, Inc.
Accepted 2026-09-11 18:01:38 ET · period of report 2026-09-09 · accession 0002087126-26-000011 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-09-11 18:01 | 2026-09-09 | BLLN | ten Bosch John Roderick | SVP of Laboratory Ops | S - Sale | $97.54 | -1,416 | 25.1K | -5% | -$138.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2026-09-09 | S | D | 1,416 | $97.54 | 25,051 | D | — | — | (F1) The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 2, 2026. |